undamentalytics Newsletter

Aspire-lakewood Holdings, Inc. revenue

Aspire-lakewood Holdings, Inc.'s revenue was $6,202 in fiscal 2025. Over the last twelve months it was $97,659.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Aspire-lakewood Holdings, Inc.: revenue history, annual
Fiscal year2025Dec 2025LTMJun 2026
Revenue698
Gross profit−0−24
Gross margin−1.9%−25.0%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue Share YoY
United States $6,153 99.2% —
Canada $30 0.5% —
United Kingdom $19 0.3% —

From Aspire-lakewood Holdings, Inc.'s 10-K filed March 30, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Pharmaceuticals: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Aspire-lakewood Holdings, Inc. $97,659 — —
Akanda Corp. $258,075 -69.2% —
PRF Technologies Ltd. $17,000 — —
Scienture Holdings, Inc. $821,315 540.6% -58.5%
60 Degrees Pharmaceuticals, Inc. $1.1m 73.2% 74.9%
China SXT Pharmaceuticals, Inc. $1.1m -34.6% —

Compare with peers

Head to head: AKAN vs ASBPASBP vs PRFXASBP vs SCNX

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Aspire-lakewood Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Aspire-lakewood Holdings, Inc.